The Journal of Pharmaceutical Health Services Research, an official journal of the Royal Pharmaceutical Society, published a research paper by Dr. Kristina M.L. Acri née Lybecker titled “State Pharmaceutical Importation Programmes: An Analysis of the Cost-effectiveness.” In the research paper, Dr. Acri analyzed 24 prescription drugs, comparing the presumed cost savings of state-sponsored drug importation…

[...]

Concerns over how much constituents pay for their medications have caused multiple states to introduce bills that would legalize drug importation. Florida’s House Bill 19 is just one example of legislators thinking that stepping outside the security of the U.S.’s drug supply chain is a smart option for their state…

[...]

As a licensed pharmacist, I’m all too familiar with patients’ difficulties getting medications they need and their physician has prescribed. As baby boomers age, pharmacists see more patients at our counters unable to obtain needed treatments for heart disease, high blood pressure, diabetes, and other chronic illnesses. This issue is now being acknowledged and a healthy debate has begun over possible solutions. But one idea policymakers shouldn’t pursue is opening up our country’s secure drug supply to medicines coming from outside our borders.

[...]

This editorial by Dr. Warren Willey was published in Idaho State Journal on July 7, 2018. Dr. Willey is an osteopathic physician who lives and works in Pocatello, Idaho. Dr. Willey says counterfeit drugs are becoming more commonplace and that people need to only purchase their medications from within the U.S.’s secure drug supply chain…

[...]